Email this article ANALYSIS OF GENE POLYMORPHISM, DETERMINING CARRIAGE OF HYPERHOMOCYSTEINEMIA IN RECURRENT ISCHEMIC STROKE IN YOUNG AND MIDDLE-AGED PATIENTS
- Authors: Skorokhodov A.P1, Dutova T.I1
-
Affiliations:
- 394036, Voronezh, Studencheskaya street, 10
- Issue: Vol XLV, No 1 (2013)
- Pages: 40-44
- Section: Articles
- URL: https://journals.eco-vector.com/1027-4898/article/view/13780
- DOI: https://doi.org/10.17816/nb13780
- ID: 13780
Cite item
Full Text
Abstract
The analysis of gene polymorphism determining carrier hyperhomocysteinemia at recurrent ischemic stroke in young and middle-aged has been performed. It was shown that the level of homocysteine in recurrent ischemic stroke is higher than in single, and the level of vitamin B12 at repeated strokes is lower than at the individual ones, and level of folic acid is decreased both at the repeated insults, and at individual. The risk of ischemic stroke increases not only in the case of a combination of several mutations in the patient, leading to hyperhomocysteinemia, but also in any other combination of factors - both genetic and exogenous. The leading role in the development of hyperhomocysteinemia at ischemic stroke in young and middle age has (GE10), gene of methionine synthase reductase MTRR.
Full Text
АНАЛИЗ ПОЛИМОРФИЗМА ГЕНОВ, ОПРЕДЕЛЯЮЩИХ НОСИТЕЛЬСТВО ГИПЕРГОМОЦИСТЕИНЕМИИ ПРИ ПОВТОРНЫХ ИШЕМИЧЕСКИХ ИНСУЛЬТАХ У ЛИЦ МОЛОДОГО И СРЕДНЕГО ВОЗРАСТА×
About the authors
Alexander P Skorokhodov
394036, Voronezh, Studencheskaya street, 10
Tatiana I Dutova
394036, Voronezh, Studencheskaya street, 10
Email: dutova80@mail.ru
References
- Деев А.С, Захарушкина И.В. Церебральные инсульты у мужчин и женщин молодого возраста. Рязань: Ряз. гос. мед. ун-т. 1998. 39 с.
- Калашникова Л.А., Добрынина Л.А., Устюжанина М.К. Гипергомоцистеинемия и поражение головного мозга // Неврология и психиатрия. 2004. №3. С. 48‒54.
- Billion S., Tribout В., Cadet E., Quennec C, Rochette J., Wheatley P. Bataille P. Hyperhomocysteinemia, folate and vitamin В12 in unsupplemented haemodialysis patients: effect of oral therapy with folic acid and vitamin B12 // Nephrol. Dial. Transplant. 2002. 17(3). P. 455‒461.
- Boushey C.J., Beresford S.A., Omenn G.S., Motulsky A.G. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease: probable benefits of increasing folic acid intakes II // J.A.M.A. 1995. Vol. 274. P. 1049‒1057.
- Brattstrom L., Wilcken D. E.L., Ohrvik J., Brudin L. Common methylenetetrahydrofolate reductase gene mutation leads to hyperhomocysteinemia but not to vascular desease. The results of meta-analysis // Circulation. 1998. Vol. 98. P. 2520‒2526.
Supplementary files
СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).